xarelto

Xarelto Lawsuits See Massive Spike in August

xarelto lawsuits spiked in august of 2015The number of Xarelto lawsuits in federal court jumped by nearly 500 over the month of August. There are currently over 1,700 Xarelto lawsuits consolidated in a multidistrict litigation in the U.S. District Court for the Eastern District of Louisiana, and if recent court records are anything to go by, the number will continue to increase rapidly in the coming months.

Xarelto is a blood-thinning drug approved by the ...

continue reading...

Xarelto: Higher Risk Same Reward?

xarelto may be no more beneficial than warfarin and be more dangerousOver 1,200 Xarelto lawsuits are pending in a multidistrict litigation in the U.S. District Court for the Eastern District of Louisiana. Xarelto plaintiffs allege that the anticoagulant drug’s manufacturers, including Bayer HealthCare Pharmaceuticals and Johnson & Johnson’s Janssen Pharmaceutical, did not provide patients and doctors with adequate warning about Xarelto’s severe bleeding risks.

Approved by the U.S. Food and Drug Administration (FDA) in 2011 ...

continue reading...

New Study: Xarelto No Safer than Warfarin in Elderly

xarelto may not be any safer than warfarin in elderly patientsJanssen Pharmaceuticals and Bayer have long insisted their blood-thinning drug Xarelto is a safer, more reliable alternative to the decades-old warfarin. However, a new study recently published in the American Heart Association’s journal Circulation suggests the popular “new-age” anticoagulant may be no safer than warfarin in terms of bleeding in elderly patients.

Xarelto was approved by the U.S. Food and Drug Administration in 2011 for ...

continue reading...

Indiana Xarelto Lawsuit Joins MDL

xarelto bleeding lawsuit filed in indianaAn Indiana man has filed a Xarelto lawsuit alleging Janssen Pharmaceutica’s popular blood thinner caused him to experience severe bleeding. The new Xarelto lawsuit will join hundreds of similar cases centralized late last year in the U.S. District Court for the Eastern District of Louisiana.

Xarelto was approved by the U.S. Food and Drug Administration in 2011 to help prevent blood clotting in patients who have undergone surgery or ...

continue reading...

New Study: Xarelto May Be Dangerous for Pregnant Women

xarelto may be harmful to pregnant mothersXarelto has long been associated with severe bleeding, but according to a new study, the popular blood thinner may also pose a risk to pregnant women and their unborn babies. The study, published last month by the American Journal of Obstetrics and Gynecology, examined the way in which rivaroxaban (Xarelto) is transported across the placenta of a pregnant woman.

Current Xarelto lawsuits focus on the risk severe bleeding, which ...

continue reading...

New Study Links Xarelto to Eye Bleeding

xarelto now linked with eye bleedingA new study has been published by the Journal of the American Medical Association Opthalmology linking use of the anticoagulant Xarelto (rivaroxaban) to eye bleeding. The study, conducted by Retina Associates of Orange County in Laguna Hills, California, observes three patients who developed spontaneous vitreous hemorrhage after starting use of Xarelto. The researchers note that all three patients were tapering off another anticoagulant at the time of their diagnoses.

Xarelto ...

continue reading...
Page 2 of 5 12345